"Weight-loss version" of Semaglutide launched in China, can anyone use it? Expert analysis

Recently, the "weight loss version" of semaglutide, "Nuoheying," was officially launched in China. Previously, the "sugar-lowering version" of semaglutide had already been launched in China, which is only approved for the indication of diabetes. During an interview, reporters learned that both the "weight loss version" and the "sugar-lowering version" of semaglutide are prescription drugs and can only be dispensed, purchased, and used with a prescription from a licensed physician or licensed assistant physician. Although the chemical components of the two are basically the same, their approved treatment indications, which refer to the patient populations for clinical treatment, are completely different